Wednesday, July 09, 2025 9:24:55 AM
Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC’s iCare+ Network
WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a leading Medicare Advantage company committed to affordable, high-quality care, today announced the launch of a new community-based pharmacy pilot program across New Jersey. Built in partnership with IPC Digital Health™, a division of Independent Pharmacy Cooperative (IPC), this initiative is designed to help seniors better manage their medications and stay healthier at home, supported by the local pharmacies they know and trust.
The program will be anchored by IPC’s iCare+™ Independent Pharmacy Network, which includes thousands of community-rooted pharmacies nationwide and many in New Jersey. These local pharmacies will deploy innovative care tools and virtual services that help Clover members with chronic conditions stay on track with their medications and avoid unnecessary hospital visits.
“This is more than a new program—it’s a new model for how we support our New Jersey members,” said Jamie Reynoso, CEO of Medicare Advantage at Clover Health. “By working with the pharmacists who are already embedded in our communities, we can deliver better care, deliver amazing customer experiences and support the independent businesses that keep New Jersey strong.”
Participating iCare+ pharmacies will use real-time tools, powered by Clover Assistant data and AI models, to monitor prescription fills, identify adherence gaps, and collaborate with local doctors and Clover’s care teams. The goal: make it easier for seniors to get the right medications at the right time, while keeping their care close to home.
“Clover Health understands that innovation doesn’t always mean centralization,” said Ashton Maaraba, President of IPC Digital Health. “This partnership helps New Jersey’s independent pharmacies lead the way in delivering smarter, more connected care.”
This new program is part of Clover’s broader commitment to investing in New Jersey communities, by combining modern technology, local relationships, and a belief that healthcare should feel personal again.
WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a leading Medicare Advantage company committed to affordable, high-quality care, today announced the launch of a new community-based pharmacy pilot program across New Jersey. Built in partnership with IPC Digital Health™, a division of Independent Pharmacy Cooperative (IPC), this initiative is designed to help seniors better manage their medications and stay healthier at home, supported by the local pharmacies they know and trust.
The program will be anchored by IPC’s iCare+™ Independent Pharmacy Network, which includes thousands of community-rooted pharmacies nationwide and many in New Jersey. These local pharmacies will deploy innovative care tools and virtual services that help Clover members with chronic conditions stay on track with their medications and avoid unnecessary hospital visits.
“This is more than a new program—it’s a new model for how we support our New Jersey members,” said Jamie Reynoso, CEO of Medicare Advantage at Clover Health. “By working with the pharmacists who are already embedded in our communities, we can deliver better care, deliver amazing customer experiences and support the independent businesses that keep New Jersey strong.”
Participating iCare+ pharmacies will use real-time tools, powered by Clover Assistant data and AI models, to monitor prescription fills, identify adherence gaps, and collaborate with local doctors and Clover’s care teams. The goal: make it easier for seniors to get the right medications at the right time, while keeping their care close to home.
“Clover Health understands that innovation doesn’t always mean centralization,” said Ashton Maaraba, President of IPC Digital Health. “This partnership helps New Jersey’s independent pharmacies lead the way in delivering smarter, more connected care.”
This new program is part of Clover’s broader commitment to investing in New Jersey communities, by combining modern technology, local relationships, and a belief that healthcare should feel personal again.
Recent CLOV News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 08:19:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:25:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 08:09:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 08:07:01 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 11:46:26 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 04/09/2026 10:12:51 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 10:03:13 PM
- Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026 • GlobeNewswire Inc. • 04/08/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 08:28:10 PM
- Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership • GlobeNewswire Inc. • 04/07/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:59:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:34:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:31:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:25:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:20:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 12:32:45 PM
- Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 • GlobeNewswire Inc. • 04/01/2026 12:30:00 PM
- MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value • PR Newswire (US) • 03/27/2026 02:15:00 PM
- MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value • PR Newswire (Canada) • 03/27/2026 02:15:00 PM
- Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients • GlobeNewswire Inc. • 03/19/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 10:11:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/18/2026 08:32:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:27:13 PM
- UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives • GlobeNewswire Inc. • 03/10/2026 12:30:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 03/06/2026 02:06:35 PM
